Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

PubMed Links for Books (Select 1423616)

1.

NMDA antagonists for stroke and head trauma: current status.

Wood PL.

Expert Opin Investig Drugs. 1998 Sep;7(9):1505-8. No abstract available.

PMID:
15992048
2.

Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways.

D'Onofrio M, Cuomo L, Battaglia G, Ngomba RT, Storto M, Kingston AE, Orzi F, De Blasi A, Di Iorio P, Nicoletti F, Bruno V.

J Neurochem. 2001 Aug;78(3):435-45. Retraction in: J Neurochem. 2014 Jun;129(6):1035.

PMID:
11483646
3.

Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.

Spooren WP, Gasparini F, Salt TE, Kuhn R.

Trends Pharmacol Sci. 2001 Jul;22(7):331-7. Review.

PMID:
11431019
4.

Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission.

Battaglia G, Bruno V, Pisani A, Centonze D, Catania MV, Calabresi P, Nicoletti F.

Mol Cell Neurosci. 2001 Jun;17(6):1071-83.

PMID:
11414795
5.

An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors.

Bruno V, Battaglia G, Copani A, Cespédes VM, Galindo MF, Ceña V, Sánchez-Prieto J, Gasparini F, Kuhn R, Flor PJ, Nicoletti F.

Eur J Neurosci. 2001 Apr;13(8):1469-78.

PMID:
11328342
6.

BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.

Carroll FY, Stolle A, Beart PM, Voerste A, Brabet I, Mauler F, Joly C, Antonicek H, Bockaert J, Müller T, Pin JP, Prézeau L.

Mol Pharmacol. 2001 May;59(5):965-73.

7.

Molecular determinants of metabotropic glutamate receptor signaling.

De Blasi A, Conn PJ, Pin J, Nicoletti F.

Trends Pharmacol Sci. 2001 Mar;22(3):114-20. Review.

PMID:
11239574
8.

The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity.

Orlando LR, Alsdorf SA, Penney JB Jr, Young AB.

Exp Neurol. 2001 Jan;167(1):196-204.

PMID:
11161608
9.

Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer1 proteins and neuronal excitation.

Ango F, Pin JP, Tu JC, Xiao B, Worley PF, Bockaert J, Fagni L.

J Neurosci. 2000 Dec 1;20(23):8710-6.

11.

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.

Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, Flor PJ, Vranesic I, Lingenhoehl K, Johnson EC, Varney M, Urban L, Kuhn R.

Neuropharmacology. 2001;40(1):1-9.

PMID:
11077065
13.
14.

The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity.

Wolfarth S, Konieczny J, Lorenc-Koci E, Ossowska K, Pilc A.

Amino Acids. 2000;19(1):95-101.

PMID:
11026478
15.

Group I and group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection.

Maiese K, Vincent A, Lin SH, Shaw T.

J Neurosci Res. 2000 Oct 15;62(2):257-72.

PMID:
11020218
17.

A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices.

Doherty AJ, Palmer MJ, Bortolotto ZA, Hargreaves A, Kingston AE, Ornstein PL, Schoepp DD, Lodge D, Collingridge GL.

Br J Pharmacol. 2000 Sep;131(2):239-44.

19.

Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective.

Bruno V, Ksiazek I, Battaglia G, Lukic S, Leonhardt T, Sauer D, Gasparini F, Kuhn R, Nicoletti F, Flor PJ.

Neuropharmacology. 2000 Sep;39(12):2223-30.

PMID:
10974306
20.

Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death.

Bruno V, Battaglia G, Ksiazek I, van der Putten H, Catania MV, Giuffrida R, Lukic S, Leonhardt T, Inderbitzin W, Gasparini F, Kuhn R, Hampson DR, Nicoletti F, Flor PJ.

J Neurosci. 2000 Sep 1;20(17):6413-20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk